Impact of Nutritional Status on Serum Lipoprotein (A) Concentration in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

Armstrong V.W. , Cremer P. , Eberle E. The association between serum LP(a) concentration and angiographically assessed coronary atherosclerosis. Atherosclerosis 1986; 62: 249–57.

Durrington P.N. , Ishola M. , Hunt L. , Arrol S. , Bhatnagar D. Apolipoprotein (a), Al, and B and parental history in men with early onset ischemic heart disease. Lancet 1988; 1: 1070–3.

Berg K. A new serum type system in man: the LP system. Acta Pathol Microbiol Scand 1963; 59: 369–82.

McBewu A.D. , Durrington P.N. Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherosclerosis. Atherosclerosis 1990; 85: 1–14.

Shoji T. , Nishizawa Y. , Nishitani H. , Yamakaya M. , Morii H. High serum lipoprotein (a) concentration in uremic patients treated with continuous ambulatory peritoneal dialysis. Clin Nephrol 1992; 38(5): 271–6.

Thillet J. , Faucher C. , Issad B. , Allouache M. , Chapman J. , Jacobs C. Lipoprotein (a) in patients treated by continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1993; 22(1): 226–32.

Anwar N. , Bhatnagar D. , Short C.D. Serum lipoprotein (a) concentration in patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993; 8(1): 71–4.

Cressman M.D. , Heyka R.J. , Paganini E.P. , O'Neil J. , Skibibski C.I. , Hoff H.F. Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992; 86: 475–82.

Acchiardo S.R. , Moore L.W. , Latour P.A. Malnutrition as a main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983; 24(Suppl 16): S199–203.

Friedewald W.T. , Levy R.I. , Fredrickson D.S. Estimation of the concentration of low-density lipoprotein concentration in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499.

Keshaviah P.R. , Nolph K.D. , Prowant B. Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 1994; 4: 1475–85.

Heymsfield S.B. , McManus C. , Stevens V. , Smith J. Muscle mass: reliable indicator of protein-energy malnutrition severity and outcome. Am J Clin Nutr 1992; 35: 1192–9.

Gokal R. , Ramos J.M. , McGurk J.G. , Ward M.K. , Kerr D.N.S. Hyperlipidemia in patients on continuous ambulatory peritoneal dialysis. Advances in peritoneal dialysis. Amsterdam: Excerpta Medica, 1981: 434–6.

Ramos J.M. , Heaton A. , McGurk J.G. , Ward M.K. , Kerr D.N.S. Sequential changes in serum lipids and their subfraction in patients receiving continuous ambulatory peritoneal dialysis. Nephron 1983; 35: 20–3.

Zenkeer G. , Koltringer P. , Bone G. , Niederkorn K. , Pfeiffer K. , Jurgens G. Lipoprotein (a) as a strong indicator for cerebrovascular disease. Stroke 1986; 17: 942–5.

Goldwasser P. , Michel M.A. , Collier J. Prealbumin and lipoprotein (a) in hemodialysis: relationships with patient and vascular access survival. Am J Kidney Dis 1993; 22(1): 215–25.

Utermann G. The mysteries of lipoprotein (a). Science 1989; 246: 904–10.

Bergstrom J. , Lindholm B. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare? Kidney Int 1993; 34: S39.

Black I.W. , Wilken D.L. Decreases in apolipoprotein (a) after renal transplantation: implications for lipoprotein (a) metabolism. Clin Chem 1992; 38(3): 353–7.

Klempler V.W.F. , Koster G.M. , Roscher A. , Haslauer F. , Bolzano K.J. Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest 1980; 65: 1483–90.

Wanner C. , Bartens W. , Walz G. , Nauck M. , Schollmeyer P. Protein loss and genetic polymorphism of apolipoprotein (a) modulate serum lipoprotein(a) in CAPD patients. Nephrol Dial Transplant 1995; 10: 75–81.